CCR2-overexpressing biomimetic carrier-free nanoplatform for enhanced cascade ferroptosis tumor therapy
- 6 May 2023
- journal article
- research article
- Published by Elsevier in Acta Biomaterialia
- Vol. 166, 604-614
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (22104073, 82104051)
- Natural Science Foundation of Shandong Province (2022HWYQ-079, ZR2020QH347, ZR2021QB119)
This publication has 34 references indexed in Scilit:
- A biodegradable MnSiO3@Fe3O4 nanoplatform for dual-mode magnetic resonance imaging guided combinatorial cancer therapyBiomaterials, 2019
- Near-infrared AIEgens as transformers to enhance tumor treatment efficacy with controllable self-assembled redox-responsive carrier-free nanodrugBiomaterials, 2019
- Nanolongan with Multiple On-Demand Conversions for Ferroptosis–Apoptosis Combined Anticancer TherapyACS Nano, 2019
- Applications of π-π stacking interactions in the design of drug-delivery systemsJournal of Controlled Release, 2019
- Synthesis of Self-Assembled Porphyrin Nanoparticle PhotosensitizersACS Nano, 2018
- Heme oxygenase-1 mediates BAY 11–7085 induced ferroptosisCancer Letters, 2018
- A pH-Responsive Yolk-Like Nanoplatform for Tumor Targeted Dual-Mode Magnetic Resonance Imaging and ChemotherapyACS Nano, 2017
- ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid compositionNature Chemical Biology, 2016
- Visualization of immediate immune responses to pioneer metastatic cells in the lungNature, 2016
- CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasisNature, 2011